| regulation of chromatin modification | GO:1903308 | 57 | 0.657 | |
| ras protein signal transduction | GO:0007265 | 77 | 0.656 | |
| histone modification | GO:0016570 | 159 | 0.463 | |
| positive regulation of cellular catabolic process | GO:0031331 | 148 | 0.457 | |
| small gtpase mediated signal transduction | GO:0007264 | 97 | 0.420 | |
| regionalization | GO:0003002 | 337 | 0.401 | |
| regulation of histone modification | GO:0031056 | 56 | 0.391 | |
| regulation of cellular catabolic process | GO:0031329 | 242 | 0.389 | |
| chromatin modification | GO:0016568 | 187 | 0.361 | |
| nucleoside metabolic process | GO:0009116 | 246 | 0.345 | |
| histone acetylation | GO:0016573 | 41 | 0.329 | |
| positive regulation of nucleoside metabolic process | GO:0045979 | 91 | 0.320 | |
| covalent chromatin modification | GO:0016569 | 163 | 0.311 | |
| histone methylation | GO:0016571 | 71 | 0.284 | |
| chromatin organization | GO:0006325 | 206 | 0.271 | |
| fibroblast proliferation | GO:0048144 | 35 | 0.258 | |
| peptidyl lysine modification | GO:0018205 | 77 | 0.253 | |
| gtp catabolic process | GO:0006184 | 143 | 0.252 | |
| regulation of chromosome organization | GO:0033044 | 83 | 0.224 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.221 | |
| rho protein signal transduction | GO:0007266 | 32 | 0.219 | |
| cerebellar granule cell precursor tangential migration | GO:0021935 | 1 | 0.211 | |
| purine ribonucleotide metabolic process | GO:0009150 | 290 | 0.201 | |
| positive regulation of gtp catabolic process | GO:0033126 | 85 | 0.192 | |
| ribonucleoside metabolic process | GO:0009119 | 245 | 0.190 | |
| nucleoside triphosphate catabolic process | GO:0009143 | 205 | 0.189 | |
| regulation of gtp catabolic process | GO:0033124 | 113 | 0.188 | |
| regulation of chromatin organization | GO:1902275 | 57 | 0.186 | |
| histone lysine methylation | GO:0034968 | 50 | 0.185 | |
| carbohydrate derivative catabolic process | GO:1901136 | 231 | 0.179 | |
| purine nucleoside triphosphate metabolic process | GO:0009144 | 226 | 0.171 | |
| regulation of binding | GO:0051098 | 111 | 0.167 | |
| positive regulation of cell development | GO:0010720 | 237 | 0.166 | |
| regulation of purine nucleotide catabolic process | GO:0033121 | 122 | 0.163 | |
| regulation of nucleotide metabolic process | GO:0006140 | 169 | 0.160 | |
| protein methylation | GO:0006479 | 81 | 0.154 | |
| regulation of ras gtpase activity | GO:0032318 | 88 | 0.153 | |
| peptidyl lysine acetylation | GO:0018394 | 45 | 0.148 | |
| methylation | GO:0032259 | 134 | 0.148 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.145 | |
| ribonucleoside catabolic process | GO:0042454 | 206 | 0.144 | |
| regulation of cell morphogenesis involved in differentiation | GO:0010769 | 151 | 0.139 | |
| stem cell differentiation | GO:0048863 | 268 | 0.139 | |
| asymmetric neuroblast division | GO:0055059 | 1 | 0.139 | |
| positive regulation of purine nucleotide catabolic process | GO:0033123 | 88 | 0.139 | |
| guanosine containing compound metabolic process | GO:1901068 | 144 | 0.129 | |
| stem cell maintenance | GO:0019827 | 130 | 0.129 | |
| ribonucleoside triphosphate metabolic process | GO:0009199 | 220 | 0.128 | |
| regulation of cell growth by extracellular stimulus | GO:0001560 | 2 | 0.127 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.123 | |
| regulation of nucleoside metabolic process | GO:0009118 | 130 | 0.121 | |
| neural precursor cell proliferation | GO:0061351 | 121 | 0.120 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.120 | |
| positive regulation of binding | GO:0051099 | 49 | 0.117 | |
| rhythmic process | GO:0048511 | 174 | 0.111 | |
| nucleotide catabolic process | GO:0009166 | 217 | 0.108 | |
| purine ribonucleoside triphosphate catabolic process | GO:0009207 | 199 | 0.106 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.105 | |
| gtp metabolic process | GO:0046039 | 144 | 0.104 | |
| purine ribonucleoside catabolic process | GO:0046130 | 205 | 0.103 | |
| regulation of cell motility | GO:2000145 | 236 | 0.103 | |
| nucleoside triphosphate metabolic process | GO:0009141 | 230 | 0.103 | |
| purine nucleotide catabolic process | GO:0006195 | 211 | 0.102 | |
| myotube differentiation | GO:0014902 | 105 | 0.100 | |
| positive regulation of ras gtpase activity | GO:0032320 | 65 | 0.099 | |
| morphogenesis of embryonic epithelium | GO:0016331 | 159 | 0.098 | |
| internal protein amino acid acetylation | GO:0006475 | 42 | 0.097 | |
| regulation of cellular response to stress | GO:0080135 | 159 | 0.097 | |
| regulation of leukocyte differentiation | GO:1902105 | 159 | 0.093 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.091 | |
| sensory perception of sour taste | GO:0050915 | 2 | 0.091 | |
| internal peptidyl lysine acetylation | GO:0018393 | 42 | 0.090 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.089 | |
| regulation of ras protein signal transduction | GO:0046578 | 114 | 0.089 | |
| maintenance of chromatin silencing | GO:0006344 | 2 | 0.088 | |
| positive regulation of dna templated transcription elongation | GO:0032786 | 2 | 0.088 | |
| guanosine containing compound catabolic process | GO:1901069 | 144 | 0.088 | |
| male gamete generation | GO:0048232 | 285 | 0.087 | |
| ribonucleotide metabolic process | GO:0009259 | 291 | 0.086 | |
| regulation of nucleotide catabolic process | GO:0030811 | 122 | 0.086 | |
| defecation | GO:0030421 | 1 | 0.083 | |
| protein autophosphorylation | GO:0046777 | 61 | 0.082 | |
| purine nucleoside catabolic process | GO:0006152 | 205 | 0.080 | |
| regulation of histone methylation | GO:0031060 | 30 | 0.079 | |
| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 220 | 0.079 | |
| rab protein signal transduction | GO:0032482 | 1 | 0.079 | |
| appendage development | GO:0048736 | 166 | 0.079 | |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.078 | |
| response to inactivity | GO:0014854 | 4 | 0.077 | |
| glycosyl compound metabolic process | GO:1901657 | 246 | 0.077 | |
| purine nucleoside metabolic process | GO:0042278 | 241 | 0.075 | |
| erythrocyte differentiation | GO:0030218 | 88 | 0.074 | |
| lung development | GO:0030324 | 164 | 0.074 | |
| calcium mediated signaling using intracellular calcium source | GO:0035584 | 3 | 0.073 | |
| regulation of protein binding | GO:0043393 | 60 | 0.072 | |
| purine ribonucleotide catabolic process | GO:0009154 | 208 | 0.071 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.070 | |
| regulation of purine nucleotide metabolic process | GO:1900542 | 169 | 0.070 | |
| leukocyte differentiation | GO:0002521 | 342 | 0.070 | |
| neuroblast fate determination | GO:0007400 | 1 | 0.069 | |
| nucleoside catabolic process | GO:0009164 | 206 | 0.069 | |
| cellular response to fluid shear stress | GO:0071498 | 4 | 0.069 | |
| skeletal muscle fiber development | GO:0048741 | 58 | 0.069 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.069 | |
| protein acylation | GO:0043543 | 64 | 0.068 | |
| ribonucleoside triphosphate catabolic process | GO:0009203 | 199 | 0.067 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.067 | |
| ion transmembrane transport | GO:0034220 | 361 | 0.067 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.067 | |
| positive regulation of nervous system development | GO:0051962 | 221 | 0.066 | |
| muscle tissue development | GO:0060537 | 308 | 0.066 | |
| glycosyl compound catabolic process | GO:1901658 | 206 | 0.065 | |
| organonitrogen compound catabolic process | GO:1901565 | 264 | 0.065 | |
| blood circulation | GO:0008015 | 195 | 0.065 | |
| asymmetric stem cell division | GO:0098722 | 3 | 0.065 | |
| protein alkylation | GO:0008213 | 81 | 0.064 | |
| appendage morphogenesis | GO:0035107 | 149 | 0.063 | |
| renal tubule development | GO:0061326 | 87 | 0.063 | |
| forebrain development | GO:0030900 | 302 | 0.062 | |
| tube formation | GO:0035148 | 140 | 0.062 | |
| regulation of histone h3 k4 methylation | GO:0051569 | 12 | 0.062 | |
| protein deacetylation | GO:0006476 | 32 | 0.061 | |
| microtubule cytoskeleton organization | GO:0000226 | 157 | 0.061 | |
| macromolecule methylation | GO:0043414 | 120 | 0.060 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.060 | |
| detection of chemical stimulus involved in sensory perception of taste | GO:0050912 | 3 | 0.060 | |
| heterocycle catabolic process | GO:0046700 | 280 | 0.060 | |
| wnt signaling pathway | GO:0016055 | 188 | 0.058 | |
| microtubule based process | GO:0007017 | 236 | 0.058 | |
| transmembrane receptor protein serine threonine kinase signaling pathway | GO:0007178 | 194 | 0.058 | |
| regulation of fibroblast proliferation | GO:0048145 | 34 | 0.057 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.057 | |
| limb morphogenesis | GO:0035108 | 149 | 0.056 | |
| negative regulation of homeostatic process | GO:0032845 | 71 | 0.056 | |
| cation homeostasis | GO:0055080 | 212 | 0.056 | |
| regulation of peptidyl lysine acetylation | GO:2000756 | 22 | 0.055 | |
| regulation of secretion by cell | GO:1903530 | 249 | 0.054 | |
| ascending thin limb development | GO:0072021 | 2 | 0.052 | |
| regulation of rho gtpase activity | GO:0032319 | 58 | 0.052 | |
| positive regulation of chromatin modification | GO:1903310 | 28 | 0.050 | |
| dna methylation | GO:0006306 | 43 | 0.050 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.049 | |
| cellular ion homeostasis | GO:0006873 | 165 | 0.048 | |
| ribonucleotide catabolic process | GO:0009261 | 208 | 0.048 | |
| gland development | GO:0048732 | 330 | 0.048 | |
| positive regulation of gtpase activity | GO:0043547 | 85 | 0.047 | |
| carbohydrate biosynthetic process | GO:0016051 | 74 | 0.047 | |
| epithelial cell migration | GO:0010631 | 63 | 0.046 | |
| cellular response to dna damage stimulus | GO:0006974 | 207 | 0.046 | |
| histone deacetylation | GO:0016575 | 26 | 0.046 | |
| lymphocyte differentiation | GO:0030098 | 242 | 0.045 | |
| purine nucleoside triphosphate catabolic process | GO:0009146 | 203 | 0.045 | |
| neuroblast differentiation | GO:0014016 | 2 | 0.045 | |
| neural tube closure | GO:0001843 | 90 | 0.044 | |
| response to oxidative stress | GO:0006979 | 123 | 0.044 | |
| regulation of histone acetylation | GO:0035065 | 19 | 0.044 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.044 | |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.043 | |
| transmission of nerve impulse | GO:0019226 | 76 | 0.043 | |
| myotube differentiation involved in skeletal muscle regeneration | GO:0014908 | 2 | 0.043 | |
| ensheathment of neurons | GO:0007272 | 76 | 0.042 | |
| neuronal action potential | GO:0019228 | 54 | 0.042 | |
| canonical wnt signaling pathway | GO:0060070 | 130 | 0.042 | |
| mesodermal cell migration | GO:0008078 | 4 | 0.042 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.042 | |
| retrograde transport vesicle recycling within golgi | GO:0000301 | 1 | 0.042 | |
| sterol homeostasis | GO:0055092 | 45 | 0.041 | |
| germ cell development | GO:0007281 | 185 | 0.041 | |
| positive regulation of transcription via serum response element binding | GO:0010735 | 1 | 0.041 | |
| carbohydrate metabolic process | GO:0005975 | 230 | 0.040 | |
| regulation of secretion | GO:0051046 | 274 | 0.040 | |
| response to peptide | GO:1901652 | 136 | 0.040 | |
| positive regulation of hydrolase activity | GO:0051345 | 148 | 0.040 | |
| neuroblast proliferation | GO:0007405 | 49 | 0.040 | |
| anion transport | GO:0006820 | 177 | 0.039 | |
| photoreceptor cell morphogenesis | GO:0008594 | 3 | 0.038 | |
| maintenance of location | GO:0051235 | 89 | 0.038 | |
| neuron projection guidance | GO:0097485 | 141 | 0.038 | |
| antimicrobial peptide production | GO:0002775 | 2 | 0.038 | |
| ossification | GO:0001503 | 216 | 0.038 | |
| alpha beta t cell differentiation | GO:0046632 | 69 | 0.037 | |
| lymphocyte homeostasis | GO:0002260 | 64 | 0.037 | |
| organonitrogen compound biosynthetic process | GO:1901566 | 192 | 0.037 | |
| regulation of protein processing | GO:0070613 | 96 | 0.037 | |
| transmembrane receptor protein tyrosine kinase signaling pathway | GO:0007169 | 247 | 0.036 | |
| neuroblast fate commitment | GO:0014017 | 1 | 0.036 | |
| regulation of striated muscle cell differentiation | GO:0051153 | 81 | 0.036 | |
| myeloid cell differentiation | GO:0030099 | 233 | 0.036 | |
| regulation of membrane potential | GO:0042391 | 192 | 0.036 | |
| neural tube development | GO:0021915 | 160 | 0.036 | |
| regulation of neuron differentiation | GO:0045664 | 281 | 0.035 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 280 | 0.035 | |
| establishment or maintenance of cell polarity | GO:0007163 | 86 | 0.035 | |
| amine metabolic process | GO:0009308 | 45 | 0.034 | |
| skeletal system development | GO:0001501 | 356 | 0.034 | |
| positive regulation of chromosome organization | GO:2001252 | 33 | 0.034 | |
| inflammatory response | GO:0006954 | 244 | 0.034 | |
| purine containing compound catabolic process | GO:0072523 | 213 | 0.034 | |
| regulation of homeostatic process | GO:0032844 | 182 | 0.034 | |
| lens development in camera type eye | GO:0002088 | 62 | 0.033 | |
| regulation of blood circulation | GO:1903522 | 93 | 0.033 | |
| regulation of sequence specific dna binding transcription factor activity | GO:0051090 | 106 | 0.033 | |
| glial cell fate determination | GO:0007403 | 3 | 0.033 | |
| negative regulation of glycolytic process | GO:0045820 | 4 | 0.033 | |
| ectodermal cell differentiation | GO:0010668 | 3 | 0.033 | |
| bone development | GO:0060348 | 120 | 0.032 | |
| muscle fiber development | GO:0048747 | 76 | 0.032 | |
| nucleoside phosphate catabolic process | GO:1901292 | 222 | 0.032 | |
| organophosphate catabolic process | GO:0046434 | 232 | 0.031 | |
| regulation of hormone secretion | GO:0046883 | 88 | 0.031 | |
| compartment pattern specification | GO:0007386 | 4 | 0.031 | |
| regulation of organelle organization | GO:0033043 | 289 | 0.031 | |
| intracellular protein transport | GO:0006886 | 204 | 0.031 | |
| sensory organ morphogenesis | GO:0090596 | 242 | 0.030 | |
| positive regulation of transcription elongation from rna polymerase ii promoter | GO:0032968 | 2 | 0.030 | |
| regulation of osteoblast differentiation | GO:0045667 | 67 | 0.030 | |
| mitotic cell cycle process | GO:1903047 | 159 | 0.030 | |
| positive regulation of cell death | GO:0010942 | 224 | 0.030 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.029 | |
| circulatory system process | GO:0003013 | 197 | 0.029 | |
| response to growth factor | GO:0070848 | 198 | 0.029 | |
| positive regulation of proteolysis involved in cellular protein catabolic process | GO:1903052 | 31 | 0.029 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.029 | |
| lung cell differentiation | GO:0060479 | 30 | 0.029 | |
| ameboidal type cell migration | GO:0001667 | 128 | 0.029 | |
| dna metabolic process | GO:0006259 | 303 | 0.029 | |
| negative regulation of intracellular protein transport | GO:0090317 | 27 | 0.029 | |
| muscle system process | GO:0003012 | 141 | 0.029 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.029 | |
| renal system development | GO:0072001 | 225 | 0.029 | |
| negative regulation of nervous system development | GO:0051961 | 156 | 0.028 | |
| cartilage development | GO:0051216 | 140 | 0.028 | |
| intra golgi vesicle mediated transport | GO:0006891 | 1 | 0.028 | |
| negative regulation of myeloid cell differentiation | GO:0045638 | 38 | 0.028 | |
| mrna transcription from rna polymerase ii promoter | GO:0042789 | 4 | 0.028 | |
| regulation of muscle tissue development | GO:1901861 | 97 | 0.028 | |
| positive regulation of nucleotide metabolic process | GO:0045981 | 114 | 0.027 | |
| epithelium migration | GO:0090132 | 63 | 0.027 | |
| cell division | GO:0051301 | 120 | 0.027 | |
| fat cell differentiation | GO:0045444 | 160 | 0.027 | |
| multicellular organismal signaling | GO:0035637 | 91 | 0.027 | |
| multi multicellular organism process | GO:0044706 | 109 | 0.027 | |
| regulation of reactive oxygen species biosynthetic process | GO:1903426 | 2 | 0.027 | |
| regulation of anion transport | GO:0044070 | 27 | 0.027 | |
| homeostasis of number of cells | GO:0048872 | 210 | 0.027 | |
| regulation of hydrolase activity | GO:0051336 | 246 | 0.027 | |
| dna alkylation | GO:0006305 | 43 | 0.027 | |
| establishment or maintenance of microtubule cytoskeleton polarity | GO:0030951 | 1 | 0.027 | |
| bone morphogenesis | GO:0060349 | 78 | 0.027 | |
| metanephric loop of henle development | GO:0072236 | 4 | 0.027 | |
| activation of immune response | GO:0002253 | 138 | 0.026 | |
| negative regulation of calcium ion dependent exocytosis | GO:0045955 | 3 | 0.026 | |
| cellular carbohydrate metabolic process | GO:0044262 | 119 | 0.026 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.026 | |
| positive regulation of notch signaling pathway | GO:0045747 | 18 | 0.026 | |
| striated muscle tissue development | GO:0014706 | 293 | 0.026 | |
| epithelial tube morphogenesis | GO:0060562 | 303 | 0.026 | |
| regulation of reactive oxygen species metabolic process | GO:2000377 | 40 | 0.026 | |
| regulation of myeloid cell differentiation | GO:0045637 | 96 | 0.025 | |
| blastocyst formation | GO:0001825 | 33 | 0.025 | |
| protein processing | GO:0016485 | 163 | 0.025 | |
| divalent inorganic cation homeostasis | GO:0072507 | 138 | 0.025 | |
| primary neural tube formation | GO:0014020 | 95 | 0.025 | |
| regulation of ral gtpase activity | GO:0032315 | 4 | 0.025 | |
| glial cell differentiation | GO:0010001 | 131 | 0.025 | |
| stem cell proliferation | GO:0072089 | 117 | 0.025 | |
| vesicle organization | GO:0016050 | 60 | 0.025 | |
| cellular lipid metabolic process | GO:0044255 | 323 | 0.025 | |
| intracellular mrna localization | GO:0008298 | 4 | 0.024 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.024 | |
| mammary gland epithelium development | GO:0061180 | 65 | 0.024 | |
| positive regulation of nucleotide catabolic process | GO:0030813 | 88 | 0.024 | |
| histone h3 acetylation | GO:0043966 | 14 | 0.024 | |
| blastocyst development | GO:0001824 | 80 | 0.024 | |
| spermatogenesis | GO:0007283 | 284 | 0.024 | |
| positive regulation of fibroblast proliferation | GO:0048146 | 20 | 0.024 | |
| metanephric ascending thin limb development | GO:0072218 | 2 | 0.024 | |
| t cell differentiation | GO:0030217 | 174 | 0.024 | |
| regulation of cell cycle | GO:0051726 | 281 | 0.024 | |
| second messenger mediated signaling | GO:0019932 | 73 | 0.024 | |
| actin cytoskeleton organization | GO:0030036 | 220 | 0.024 | |
| protein deacylation | GO:0035601 | 36 | 0.024 | |
| cellular response to peptide | GO:1901653 | 92 | 0.023 | |
| regulation of toll signaling pathway | GO:0008592 | 1 | 0.023 | |
| cellular macromolecule catabolic process | GO:0044265 | 206 | 0.023 | |
| cell fate commitment | GO:0045165 | 210 | 0.023 | |
| regulation of cardiac cell fate specification | GO:2000043 | 1 | 0.023 | |
| lipid biosynthetic process | GO:0008610 | 179 | 0.023 | |
| protein maturation | GO:0051604 | 176 | 0.022 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.022 | |
| positive regulation of chromatin binding | GO:0035563 | 3 | 0.022 | |
| t cell activation | GO:0042110 | 289 | 0.022 | |
| cellular response to organonitrogen compound | GO:0071417 | 145 | 0.022 | |
| negative regulation of protein phosphorylation | GO:0001933 | 126 | 0.022 | |
| ovarian follicle development | GO:0001541 | 40 | 0.022 | |
| spermatid differentiation | GO:0048515 | 115 | 0.022 | |
| muscle cell development | GO:0055001 | 133 | 0.021 | |
| defense response to other organism | GO:0098542 | 197 | 0.021 | |
| myeloid cell homeostasis | GO:0002262 | 114 | 0.021 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.021 | |
| basal protein localization | GO:0045175 | 1 | 0.021 | |
| placenta blood vessel development | GO:0060674 | 31 | 0.021 | |
| regulation of rab protein signal transduction | GO:0032483 | 8 | 0.021 | |
| spleen development | GO:0048536 | 39 | 0.021 | |
| regulation of myotube differentiation | GO:0010830 | 62 | 0.021 | |
| regulation of neuron migration | GO:2001222 | 22 | 0.020 | |
| regulation of cell cycle process | GO:0010564 | 160 | 0.020 | |
| cation transport | GO:0006812 | 399 | 0.020 | |
| regulation of transforming growth factor beta receptor signaling pathway | GO:0017015 | 43 | 0.020 | |
| female sex differentiation | GO:0046660 | 84 | 0.020 | |
| respiratory tube development | GO:0030323 | 167 | 0.020 | |
| negative regulation of sequence specific dna binding transcription factor activity | GO:0043433 | 40 | 0.020 | |
| forebrain neuron differentiation | GO:0021879 | 52 | 0.020 | |
| protein localization to plasma membrane | GO:0072659 | 57 | 0.019 | |
| regulation of carbohydrate metabolic process | GO:0006109 | 75 | 0.019 | |
| neuron migration | GO:0001764 | 122 | 0.019 | |
| neural tube formation | GO:0001841 | 108 | 0.019 | |
| positive regulation of anterior head development | GO:2000744 | 2 | 0.019 | |
| phospholipid metabolic process | GO:0006644 | 87 | 0.019 | |
| establishment of protein localization to golgi | GO:0072600 | 1 | 0.019 | |
| cellular response to peptide hormone stimulus | GO:0071375 | 92 | 0.019 | |
| calcium mediated signaling | GO:0019722 | 46 | 0.019 | |
| regulation of fat cell differentiation | GO:0045598 | 81 | 0.019 | |
| regulation of ovulation | GO:0060278 | 3 | 0.019 | |
| cell proliferation in forebrain | GO:0021846 | 30 | 0.018 | |
| skeletal system morphogenesis | GO:0048705 | 203 | 0.018 | |
| stem cell development | GO:0048864 | 219 | 0.018 | |
| negative regulation of cell development | GO:0010721 | 169 | 0.018 | |
| alcohol metabolic process | GO:0006066 | 116 | 0.018 | |
| intrinsic apoptotic signaling pathway in response to dna damage | GO:0008630 | 57 | 0.018 | |
| cell fate determination | GO:0001709 | 32 | 0.018 | |
| carbon catabolite activation of transcription from rna polymerase ii promoter | GO:0000436 | 4 | 0.018 | |
| regulation of response to dna damage stimulus | GO:2001020 | 34 | 0.018 | |
| leukocyte homeostasis | GO:0001776 | 79 | 0.018 | |
| striated muscle cell development | GO:0055002 | 125 | 0.018 | |
| cation transmembrane transport | GO:0098655 | 266 | 0.018 | |
| stress activated mapk cascade | GO:0051403 | 80 | 0.018 | |
| regulation of ossification | GO:0030278 | 112 | 0.018 | |
| circadian rhythm | GO:0007623 | 114 | 0.018 | |
| epithelial tube formation | GO:0072175 | 130 | 0.018 | |
| positive regulation of purine nucleotide metabolic process | GO:1900544 | 114 | 0.018 | |
| purine ribonucleoside metabolic process | GO:0046128 | 241 | 0.017 | |
| dna modification | GO:0006304 | 50 | 0.017 | |
| regulation of sphingolipid mediated signaling pathway | GO:1902068 | 2 | 0.017 | |
| regulation of synaptic growth at neuromuscular junction | GO:0008582 | 4 | 0.017 | |
| regulation of cellular carbohydrate metabolic process | GO:0010675 | 75 | 0.017 | |
| regulation of cell projection organization | GO:0031344 | 206 | 0.017 | |
| central nervous system neuron differentiation | GO:0021953 | 162 | 0.017 | |
| regulation of transmembrane receptor protein serine threonine kinase signaling pathway | GO:0090092 | 112 | 0.017 | |
| peripheral nervous system development | GO:0007422 | 53 | 0.017 | |
| transforming growth factor beta receptor signaling pathway | GO:0007179 | 71 | 0.017 | |
| histone h3 k4 trimethylation | GO:0080182 | 5 | 0.017 | |
| positive regulation of histone acetylation | GO:0035066 | 8 | 0.017 | |
| positive regulation of protein binding | GO:0032092 | 29 | 0.017 | |
| regulation of transcription from rna polymerase ii promoter in response to hypoxia | GO:0061418 | 2 | 0.017 | |
| nucleotide biosynthetic process | GO:0009165 | 78 | 0.017 | |
| negative regulation of interleukin 2 production | GO:0032703 | 8 | 0.017 | |
| negative regulation of immune system process | GO:0002683 | 209 | 0.017 | |
| lipid homeostasis | GO:0055088 | 63 | 0.017 | |
| organic hydroxy compound metabolic process | GO:1901615 | 203 | 0.017 | |
| negative regulation of intracellular signal transduction | GO:1902532 | 167 | 0.017 | |
| somitogenesis | GO:0001756 | 69 | 0.017 | |
| cell migration involved in endocardial cushion formation | GO:0003273 | 3 | 0.016 | |
| regulation of cellular protein catabolic process | GO:1903362 | 61 | 0.016 | |
| organic hydroxy compound biosynthetic process | GO:1901617 | 77 | 0.016 | |
| cellular protein catabolic process | GO:0044257 | 155 | 0.016 | |
| tissue migration | GO:0090130 | 68 | 0.016 | |
| cellular response to transforming growth factor beta stimulus | GO:0071560 | 88 | 0.016 | |
| cellular response to organic cyclic compound | GO:0071407 | 87 | 0.016 | |
| epithalamus development | GO:0021538 | 2 | 0.016 | |
| cell cell adhesion via plasma membrane adhesion molecules | GO:0098742 | 40 | 0.016 | |
| spermatid development | GO:0007286 | 108 | 0.016 | |
| proteolysis involved in cellular protein catabolic process | GO:0051603 | 147 | 0.016 | |
| chemotaxis | GO:0006935 | 247 | 0.016 | |
| telencephalon development | GO:0021537 | 186 | 0.016 | |
| proteasomal protein catabolic process | GO:0010498 | 98 | 0.016 | |
| response to reactive oxygen species | GO:0000302 | 56 | 0.016 | |
| production of molecular mediator of immune response | GO:0002440 | 103 | 0.016 | |
| establishment of protein localization to organelle | GO:0072594 | 118 | 0.016 | |
| myotube cell development | GO:0014904 | 60 | 0.016 | |
| negative regulation of protein modification process | GO:0031400 | 163 | 0.016 | |
| mesonephros development | GO:0001823 | 97 | 0.016 | |
| negative regulation of t cell activation | GO:0050868 | 65 | 0.016 | |
| regulation of intrinsic apoptotic signaling pathway | GO:2001242 | 61 | 0.016 | |
| cdc42 protein signal transduction | GO:0032488 | 0 | 0.016 | |
| positive regulation of organelle organization | GO:0010638 | 128 | 0.016 | |
| negative regulation of glial cell proliferation | GO:0060253 | 4 | 0.016 | |
| regulation of protein deacetylation | GO:0090311 | 17 | 0.016 | |
| retina development in camera type eye | GO:0060041 | 119 | 0.016 | |
| adult behavior | GO:0030534 | 135 | 0.016 | |
| rhombomere formation | GO:0021594 | 1 | 0.016 | |
| notch signaling pathway | GO:0007219 | 71 | 0.016 | |
| small molecule biosynthetic process | GO:0044283 | 132 | 0.016 | |
| myelination | GO:0042552 | 74 | 0.016 | |
| heart morphogenesis | GO:0003007 | 178 | 0.016 | |
| cellular response to lipid | GO:0071396 | 145 | 0.015 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.015 | |
| positive regulation of transferase activity | GO:0051347 | 167 | 0.015 | |
| negative regulation of protein maturation | GO:1903318 | 79 | 0.015 | |
| axonogenesis | GO:0007409 | 274 | 0.015 | |
| compound eye development | GO:0048749 | 1 | 0.015 | |
| cellular chemical homeostasis | GO:0055082 | 215 | 0.015 | |
| positive regulation of cyclin dependent protein serine threonine kinase activity | GO:0045737 | 6 | 0.015 | |
| regulation of lymphocyte differentiation | GO:0045619 | 107 | 0.015 | |
| skin development | GO:0043588 | 220 | 0.015 | |
| protein catabolic process | GO:0030163 | 221 | 0.015 | |
| regulation of protein maturation | GO:1903317 | 96 | 0.015 | |
| sensory system development | GO:0048880 | 3 | 0.015 | |
| regulation of antimicrobial humoral response | GO:0002759 | 3 | 0.015 | |
| negative regulation of osteoblast proliferation | GO:0033689 | 4 | 0.015 | |
| liver development | GO:0001889 | 66 | 0.015 | |
| sequestering of calcium ion | GO:0051208 | 18 | 0.015 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.015 | |
| regulation of bmp signaling pathway | GO:0030510 | 60 | 0.015 | |
| reactive oxygen species biosynthetic process | GO:1903409 | 8 | 0.015 | |
| cellular metal ion homeostasis | GO:0006875 | 151 | 0.015 | |
| palate development | GO:0060021 | 76 | 0.015 | |
| smoothened signaling pathway | GO:0007224 | 105 | 0.015 | |
| negative regulation of cellular response to growth factor stimulus | GO:0090288 | 46 | 0.014 | |
| chemorepulsion of branchiomotor axon | GO:0021793 | 1 | 0.014 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 197 | 0.014 | |
| sequestering of metal ion | GO:0051238 | 19 | 0.014 | |
| regulation of neuron projection development | GO:0010975 | 169 | 0.014 | |
| translation | GO:0006412 | 93 | 0.014 | |
| jnk cascade | GO:0007254 | 72 | 0.014 | |
| regulation of cell migration involved in sprouting angiogenesis | GO:0090049 | 4 | 0.014 | |
| hepaticobiliary system development | GO:0061008 | 67 | 0.014 | |
| wnt signaling pathway involved in somitogenesis | GO:0090244 | 4 | 0.014 | |
| anatomical structure homeostasis | GO:0060249 | 145 | 0.014 | |
| developmental maturation | GO:0021700 | 193 | 0.014 | |
| synaptic transmission | GO:0007268 | 329 | 0.014 | |
| hematopoietic progenitor cell differentiation | GO:0002244 | 143 | 0.014 | |
| striated muscle contraction | GO:0006941 | 45 | 0.014 | |
| regulation of kinase activity | GO:0043549 | 249 | 0.014 | |
| response to insulin | GO:0032868 | 100 | 0.014 | |
| regulation of vesicle mediated transport | GO:0060627 | 139 | 0.014 | |
| cellular calcium ion homeostasis | GO:0006874 | 119 | 0.014 | |
| positive regulation of thymocyte migration | GO:2000412 | 2 | 0.014 | |
| negative regulation of chromatin modification | GO:1903309 | 19 | 0.014 | |
| negative regulation of neuron differentiation | GO:0045665 | 101 | 0.014 | |
| cardiac right atrium morphogenesis | GO:0003213 | 3 | 0.014 | |
| development of primary sexual characteristics | GO:0045137 | 143 | 0.014 | |
| carboxylic acid biosynthetic process | GO:0046394 | 86 | 0.014 | |
| protein homotrimerization | GO:0070207 | 4 | 0.014 | |
| positive regulation of mitotic metaphase anaphase transition | GO:0045842 | 2 | 0.014 | |
| positive regulation of rab gtpase activity | GO:0032851 | 7 | 0.014 | |
| negative regulation of cellular component organization | GO:0051129 | 194 | 0.014 | |
| organelle localization | GO:0051640 | 179 | 0.014 | |
| retina morphogenesis in camera type eye | GO:0060042 | 45 | 0.014 | |
| cytoplasmic transport | GO:0016482 | 234 | 0.014 | |
| positive regulation of protein acetylation | GO:1901985 | 9 | 0.014 | |
| regulation of ureteric bud formation | GO:0072106 | 3 | 0.014 | |
| heart contraction | GO:0060047 | 93 | 0.014 | |
| positive regulation of rho gtpase activity | GO:0032321 | 41 | 0.013 | |
| glycerolipid biosynthetic process | GO:0045017 | 50 | 0.013 | |
| meiotic nuclear division | GO:0007126 | 115 | 0.013 | |
| cellular response to lipopolysaccharide | GO:0071222 | 77 | 0.013 | |
| response to muscle inactivity | GO:0014870 | 4 | 0.013 | |
| hindbrain development | GO:0030902 | 128 | 0.013 | |
| negative regulation of golgi to plasma membrane protein transport | GO:0042997 | 3 | 0.013 | |
| epithelial cell proliferation | GO:0050673 | 174 | 0.013 | |
| rhombomere morphogenesis | GO:0021593 | 2 | 0.013 | |
| phosphatidylserine exposure on apoptotic cell surface | GO:0070782 | 2 | 0.013 | |
| negative regulation of blood vessel endothelial cell migration | GO:0043537 | 3 | 0.013 | |
| cellular response to growth factor stimulus | GO:0071363 | 197 | 0.013 | |
| limb development | GO:0060173 | 166 | 0.013 | |
| nitrogen compound transport | GO:0071705 | 271 | 0.013 | |
| regulation of cell proliferation involved in outflow tract morphogenesis | GO:1901963 | 2 | 0.013 | |
| cellular homeostasis | GO:0019725 | 240 | 0.013 | |
| positive regulation of cell cycle | GO:0045787 | 92 | 0.013 | |
| cell substrate adhesion | GO:0031589 | 130 | 0.013 | |
| cellular response to ethanol | GO:0071361 | 3 | 0.013 | |
| glossopharyngeal nerve morphogenesis | GO:0021615 | 4 | 0.013 | |
| intracellular steroid hormone receptor signaling pathway | GO:0030518 | 29 | 0.013 | |
| regulation of establishment of protein localization | GO:0070201 | 181 | 0.013 | |
| myelination in peripheral nervous system | GO:0022011 | 19 | 0.013 | |
| action potential | GO:0001508 | 78 | 0.013 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.013 | |
| embryonic limb morphogenesis | GO:0030326 | 126 | 0.013 | |
| response to hypoxia | GO:0001666 | 58 | 0.013 | |
| cd4 positive cd25 positive alpha beta regulatory t cell differentiation | GO:0002361 | 4 | 0.013 | |
| protein localization to organelle | GO:0033365 | 185 | 0.013 | |
| locomotory behavior | GO:0007626 | 195 | 0.013 | |
| peptide secretion | GO:0002790 | 114 | 0.013 | |
| mitotic cell cycle | GO:0000278 | 195 | 0.013 | |
| negative regulation of transmembrane receptor protein serine threonine kinase signaling pathway | GO:0090101 | 61 | 0.013 | |
| regulation of inositol trisphosphate biosynthetic process | GO:0032960 | 3 | 0.013 | |
| negative regulation of adenylate cyclase activity | GO:0007194 | 1 | 0.013 | |
| cellular response to cytokine stimulus | GO:0071345 | 189 | 0.013 | |
| positive regulation of programmed cell death | GO:0043068 | 218 | 0.013 | |
| regulation of cytokine production | GO:0001817 | 266 | 0.013 | |
| intracellular receptor signaling pathway | GO:0030522 | 74 | 0.013 | |
